Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 455

1.

Update on partial response in depression.

Thase ME.

J Clin Psychiatry. 2009;70 Suppl 6:4-9. doi: 10.4088/JCP.8133su1c.01. Review.

2.

Treatment-resistant depression: prevalence, risk factors, and treatment strategies.

Thase ME.

J Clin Psychiatry. 2011 May;72(5):e18. doi: 10.4088/JCP.8133tx4c.

3.
4.

Managing partial response or nonresponse: switching, augmentation, and combination strategies for major depressive disorder.

Papakostas GI.

J Clin Psychiatry. 2009;70 Suppl 6:16-25. doi: 10.4088/JCP.8133su1c.03. Review.

5.

[Antidepressants and their onset of action: a major clinical, methodological and pronostical issue].

Gourion D.

Encephale. 2008 Jan;34(1):73-81. doi: 10.1016/j.encep.2007.12.001. Epub 2008 Feb 5. Review. French.

PMID:
18514154
6.

Rationale for, barriers to, and appropriate medication for the long-term treatment of depression.

Nutt DJ.

J Clin Psychiatry. 2010;71 Suppl E1:e02. doi: 10.4088/JCP.9058se1c.02gry.

7.

Family history of depression and therapeutic outcome: findings from STAR*D.

Husain MM, Rush AJ, Wisniewski SR, McClintock SM, Fava M, Nierenberg AA, Davis L, Balasubramani GK, Young E, Albala AA, Trivedi MH.

J Clin Psychiatry. 2009 Feb;70(2):185-95. Epub 2008 Dec 2.

PMID:
19192454
8.

Achieving remission and managing relapse in depression.

Thase ME.

J Clin Psychiatry. 2003;64 Suppl 18:3-7.

9.

[Severe depression : pharmacological treatments].

Mouchabac S.

Encephale. 2009 Dec;35 Suppl 7:S319-24. doi: 10.1016/S0013-7006(09)73495-5. Review. French.

PMID:
20141796
10.

Enhancing the efficacy of antidepressants with psychotherapy.

Petersen TJ.

J Psychopharmacol. 2006 May;20(3 Suppl):19-28. Review.

PMID:
16644768
11.

Use of atypical antipsychotics in refractory depression and anxiety.

Nemeroff CB.

J Clin Psychiatry. 2005;66 Suppl 8:13-21. Review.

12.

Consensus recommendations for improving adherence, self-management, and outcomes in patients with depression.

Trivedi MH, Lin EH, Katon WJ.

CNS Spectr. 2007 Aug;12(8 Suppl 13):1-27. Review.

PMID:
17986951
13.

Major depressive disorder treatment guidelines in America and Europe.

Davidson JR.

J Clin Psychiatry. 2010;71 Suppl E1:e04. doi: 10.4088/JCP.9058se1c.04gry.

14.

Treating each and every depressed patient.

Kennedy SH.

J Psychopharmacol. 2008 Sep;22(7 Suppl):19-23. doi: 10.1177/0269881108093270. Review.

PMID:
18753279
15.

Lithium's emerging role in the treatment of refractory major depressive episodes: augmentation of antidepressants.

Bauer M, Adli M, Bschor T, Pilhatsch M, Pfennig A, Sasse J, Schmid R, Lewitzka U.

Neuropsychobiology. 2010;62(1):36-42. doi: 10.1159/000314308. Epub 2010 May 7. Review.

16.

Advantages and disadvantages of combination treatment with antipsychotics ECNP Consensus Meeting, March 2008, Nice.

Goodwin G, Fleischhacker W, Arango C, Baumann P, Davidson M, de Hert M, Falkai P, Kapur S, Leucht S, Licht R, Naber D, O'Keane V, Papakostas G, Vieta E, Zohar J.

Eur Neuropsychopharmacol. 2009 Jul;19(7):520-32. doi: 10.1016/j.euroneuro.2009.04.003. Epub 2009 May 2.

PMID:
19411165
17.

Outcomes in major depressive disorder: the evolving concept of remission and its implications for treatment.

Möller HJ.

World J Biol Psychiatry. 2008;9(2):102-14. doi: 10.1080/15622970801981606. Review.

PMID:
18428079
18.

Optimizing pharmacotherapy of generalized anxiety disorder to achieve remission.

Pollack MH.

J Clin Psychiatry. 2001;62 Suppl 19:20-5. Review.

19.

First-line pharmacotherapy approaches for generalized anxiety disorder.

Davidson JR.

J Clin Psychiatry. 2009;70 Suppl 2:25-31. Review.

20.

Medication use patterns and two-year outcome in first-admission patients with major depressive disorder with psychotic features.

Craig TJ, Grossman S, Bromet EJ, Fochtmann LJ, Carlson GA.

Compr Psychiatry. 2007 Nov-Dec;48(6):497-503. Epub 2007 Aug 20.

PMID:
17954133

Supplemental Content

Support Center